On 11/7/23, Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 14.2%, closing at $16.73. Relative to the market the stock has been weak over the last nine months but has risen 22.9% during the last week.
Current PriceTarget Research Rating
NEO is expected to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Neogenomics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Neogenomics has a neutral Power Rating of 48 but a very low Appreciation Score of 14, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment